Role of m6A Methylation in the Occurrence and Development of Heart Failure

N6-methyladenosine (m6A) RNA methylation is one of the most common epigenetic modifications in RNA nucleotides. It is known that m6A methylation is involved in regulation, including gene expression, homeostasis, mRNA stability and other biological processes, affecting metabolism and a variety of bio...

Full description

Bibliographic Details
Main Authors: Shaowei Fan, Yuanhui Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.892113/full
_version_ 1811343155262390272
author Shaowei Fan
Yuanhui Hu
author_facet Shaowei Fan
Yuanhui Hu
author_sort Shaowei Fan
collection DOAJ
description N6-methyladenosine (m6A) RNA methylation is one of the most common epigenetic modifications in RNA nucleotides. It is known that m6A methylation is involved in regulation, including gene expression, homeostasis, mRNA stability and other biological processes, affecting metabolism and a variety of biochemical regulation processes, and affecting the occurrence and development of a variety of diseases. Cardiovascular disease has high morbidity, disability rate and mortality in the world, of which heart failure is the final stage. Deeper understanding of the potential molecular mechanism of heart failure and exploring more effective treatment strategies will bring good news to the sick population. At present, m6A methylation is the latest research direction, which reveals some potential links between epigenetics and pathogenesis of heart failure. And m6A methylation will bring new directions and ideas for the prevention, diagnosis and treatment of heart failure. The purpose of this paper is to review the physiological and pathological mechanisms of m6A methylation that may be involved in cardiac remodeling in heart failure, so as to explain the possible role of m6A methylation in the occurrence and development of heart failure. And we hope to help m6A methylation obtain more in-depth research in the occurrence and development of heart failure.
first_indexed 2024-04-13T19:24:42Z
format Article
id doaj.art-9010c92681e542cd9430de3cbdbfeaa7
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-13T19:24:42Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-9010c92681e542cd9430de3cbdbfeaa72022-12-22T02:33:24ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-06-01910.3389/fcvm.2022.892113892113Role of m6A Methylation in the Occurrence and Development of Heart FailureShaowei FanYuanhui HuN6-methyladenosine (m6A) RNA methylation is one of the most common epigenetic modifications in RNA nucleotides. It is known that m6A methylation is involved in regulation, including gene expression, homeostasis, mRNA stability and other biological processes, affecting metabolism and a variety of biochemical regulation processes, and affecting the occurrence and development of a variety of diseases. Cardiovascular disease has high morbidity, disability rate and mortality in the world, of which heart failure is the final stage. Deeper understanding of the potential molecular mechanism of heart failure and exploring more effective treatment strategies will bring good news to the sick population. At present, m6A methylation is the latest research direction, which reveals some potential links between epigenetics and pathogenesis of heart failure. And m6A methylation will bring new directions and ideas for the prevention, diagnosis and treatment of heart failure. The purpose of this paper is to review the physiological and pathological mechanisms of m6A methylation that may be involved in cardiac remodeling in heart failure, so as to explain the possible role of m6A methylation in the occurrence and development of heart failure. And we hope to help m6A methylation obtain more in-depth research in the occurrence and development of heart failure.https://www.frontiersin.org/articles/10.3389/fcvm.2022.892113/fullm6A methylationheart failurecardiovascular diseasecalcium homeostasisautophagy
spellingShingle Shaowei Fan
Yuanhui Hu
Role of m6A Methylation in the Occurrence and Development of Heart Failure
Frontiers in Cardiovascular Medicine
m6A methylation
heart failure
cardiovascular disease
calcium homeostasis
autophagy
title Role of m6A Methylation in the Occurrence and Development of Heart Failure
title_full Role of m6A Methylation in the Occurrence and Development of Heart Failure
title_fullStr Role of m6A Methylation in the Occurrence and Development of Heart Failure
title_full_unstemmed Role of m6A Methylation in the Occurrence and Development of Heart Failure
title_short Role of m6A Methylation in the Occurrence and Development of Heart Failure
title_sort role of m6a methylation in the occurrence and development of heart failure
topic m6A methylation
heart failure
cardiovascular disease
calcium homeostasis
autophagy
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.892113/full
work_keys_str_mv AT shaoweifan roleofm6amethylationintheoccurrenceanddevelopmentofheartfailure
AT yuanhuihu roleofm6amethylationintheoccurrenceanddevelopmentofheartfailure